Medicine and Health Sciences Commons^™

Jefferson Alumni Bulletin – Volume 50, Number 1, December 2000

The Bulletin (formerly the Jefferson Medical College Alumni Bulletin)

Jefferson Alumni Bulletin – Volume 50, Number 1, December 2000 Helping troubled teens to heal, page 4 Where does Jefferson go next? Asks Dr. Gonnella, page 8 Grave Robbers and Jefferson’s anatomist-Surgeons in the 19th century, page 10 New professorship in health policy, a rare field, page 16 Alumni Deans and department chairs: Jeffersonians at the helm at other Schools, page 23 A surgeon puts his heart into service abroad, page 26

Technology Evaluation: Pro-542, Progenics Pharmaceuticals Inc., Muhammad Mukhtar, Zahida Parveen, Roger J Pomerantz

Department of Medicine Faculty Papers

Progenics's rCD4-IgG2 (PRO-542) is a recombinant fusion protein, which has been developed using the company's Universal Antiviral Binding (UnAB) technology, and is in phase I/II clinical trials for the treatment of human immunodeficiency virus type I (HIV-1) infection [273391]. At the beginning of 1997, Progenics received a Phase II Small Business Innovation Research Program (SBIR) grant from the National Institute of Allergy and Infectious diseases (NIAID) to fund the development of PRO-542 [236048]. A further grant of $2.7 million was awarded in August 1998 for the clinical evaluation of PRO-542 and other anti-HIV therapies [294200]. Progenics is collaborating with the …

Jefferson Alumni Bulletin – Volume Xlix, Number 4, September 2000

The Bulletin (formerly the Jefferson Medical College Alumni Bulletin)

Jefferson Alumni Bulletin – Volume XLIX, Number 4, September 2000 Next board chair is Douglas MacMaster, Esg, page 8 Tom Nasca’75 is honored with portrait – and new post, page 8 West coast transplant expert heads surgery, page 9 Alumni awards honor researchers in AIDS and pediatric immunology, page 11 The choir at 30: in perfect health, page 13 Alumni-related giving nears $10 million, page 16 Two medical schools select Jeff Alumni as their top executives, page 41 Two schools establish professorships honoring Jeffersonians, page 43

Jefferson Alumni Bulletin – Volume Xlix, Number 3, June 2000

The Bulletin (formerly the Jefferson Medical College Alumni Bulletin)

Jefferson Alumni Bulletin – Volume XLIX, Number 3, June 2000 Synergy of clinical skills and behavioral medicine, page 4 African-American students at Jefferson, page 8 Competency based training: a new paradigm?, page 15 An answer on acute respiratory distress syndrome, page 17 FHIT gene implicated in many types of tumors, page 17 Pinpointing genetics of hereditary colorectal cancer, page 19 Phil Marone’57: associate Dean for Alumni relations, page 25

Evaluating The Sensitivity Of The Nanostrong Ncounter® Analysis System To Determine Gene Expression Changes Associated With Chemotherapy Treatment, Katerina Dukleska, Md, Christopher W. Schultz, Bs, Mahsa Zarei, Phd, David Mckeown, Md, Charles J. Yeo, Md, Jonathan Brody, Phd, Jordan M. Winter, Md

Department of Surgery Posters

Introduction

• Pancreatic ductal adenocarcinoma (PDA) remains a deadly disease with a 5-year survival of 8% for all stages combined (Siegel RL et al.). Currently, it’s the third leading cause of cancer-related deaths in the United States and by 2020 it is projected to become the second leading cause (Rahib L, et al).
• The poor prognosis in PDA is in part due to the limited therapies that are currently available.
• This highlights the importance of high-throughput technologies for gene expression analyses and drug screens.
• A recently developed NanoString Technologies nCounter® analysis system, an example of high-throughput technology, utilizes a color-coded barcode …

2000 Commencement For College Of Health Professions

Jefferson College of Nursing Commencements

No abstract provided.

Jefferson Alumni Bulletin – Volume Xlix, Number 2, March 2000

The Bulletin (formerly the Jefferson Medical College Alumni Bulletin)

Jefferson Alumni Bulletin – Volume XLIX, Number 2, March 2000 Integrative medicine: Broadening the mainstream, page 4 Orthopaedics circa 2013, page 8 Doctoring a sickly system: medical errors, page 10 The two logos: university and health system, page 12 University expands neuroscience programs; Wills eye to construct sophisticated new building, page 14 Jeff hosts international medical students program, page 17 Rb2 gene therapy could shrink lung tumors, and may improve angioplasty, page 19 Gene repair could fix various inherited diseases, page 20 Alumni affairs: Events, notices, dates to remember, page 22

A Cultivated Taste For Yeast., C Brenner

Kimmel Cancer Center Faculty Papers

The availability of complete genomic sequences of Saccharomyces cerevisiae has catalyzed a cultural change in the practice of yeast biology, providing opportunities to develop high throughput techniques to define protein function, to define drug targets, and to discover and characterize drugs.